- Home
- WLGS vs DTIL Comparison
WLGS vs DTIL Comparison
Compare WLGS & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLGS
- DTIL
- Stock Information
- Founded
- WLGS 1981
- DTIL 2006
- Country
- WLGS Hong Kong
- DTIL United States
- Employees
- WLGS N/A
- DTIL N/A
- Industry
- WLGS Engineering & Construction
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- WLGS Consumer Discretionary
- DTIL Health Care
- Exchange
- WLGS Nasdaq
- DTIL Nasdaq
- Market Cap
- WLGS 50.7M
- DTIL 59.0M
- IPO Year
- WLGS 2023
- DTIL 2019
- Fundamental
- Price
- WLGS $4.17
- DTIL $7.96
- Analyst Decision
- WLGS
- DTIL Strong Buy
- Analyst Count
- WLGS 0
- DTIL 2
- Target Price
- WLGS N/A
- DTIL $39.50
- AVG Volume (30 Days)
- WLGS 107.1K
- DTIL 97.7K
- Earning Date
- WLGS 11-26-2024
- DTIL 11-04-2024
- Dividend Yield
- WLGS N/A
- DTIL N/A
- EPS Growth
- WLGS N/A
- DTIL N/A
- EPS
- WLGS N/A
- DTIL 1.45
- Revenue
- WLGS $6,825,879.00
- DTIL $75,096,000.00
- Revenue This Year
- WLGS N/A
- DTIL $59.44
- Revenue Next Year
- WLGS N/A
- DTIL N/A
- P/E Ratio
- WLGS N/A
- DTIL $5.42
- Revenue Growth
- WLGS 63.69
- DTIL 43.62
- 52 Week Low
- WLGS $0.40
- DTIL $7.67
- 52 Week High
- WLGS $5.00
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- WLGS 60.36
- DTIL 35.93
- Support Level
- WLGS $3.15
- DTIL $8.25
- Resistance Level
- WLGS $5.00
- DTIL $8.51
- Average True Range (ATR)
- WLGS 0.65
- DTIL 0.37
- MACD
- WLGS 0.09
- DTIL -0.01
- Stochastic Oscillator
- WLGS 61.43
- DTIL 4.27
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.